Astex Pharmaceuticals, Inc
DelistedCIK 919722fmd_1RKG9F6R09GVYW8FVXRTRHGDP9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2013, 14 periods
Latest annual · FY2012
Millions- Total revenues
- 83
- Operating income
- (7)
- Free cash flow
- 17
Latest quarter · Q2 FY2013
Millions- Total revenues
- 17
- Operating income
- (7)
- Free cash flow
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +26.3%
Astex Pharmaceuticals, Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $83.2 million | $66.9 million | +24.3% | 10-K 2013-03-18 · proof |
| Operating income | -$7.1 million | $2.4 million | -392.4% | 10-K 2013-03-18 · proof |
| Cash from operating activities | $18 million | $12.4 million | +45.9% | 10-K 2013-03-18 · proof |
| Free cash flow | $17 million | $11 million | +54.8% | 10-K 2013-03-18 · proof |
| Total assets | $275.2 million | $276.9 million | -0.6% | 10-K 2013-03-18 · proof |
| Total liabilities | $38.2 million | $56.9 million | -32.9% | 10-K 2013-03-18 · proof |
| Cash and cash equivalents | $15.5 million | $39.8 million | -61.1% | 10-K 2013-03-18 · proof |
- What was Astex Pharmaceuticals, Inc's revenue in fiscal 2012?
- Astex Pharmaceuticals, Inc reported revenue of $83.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $66.9 million the year before (+24.3%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What was Astex Pharmaceuticals, Inc's operating income in fiscal 2012?
- Astex Pharmaceuticals, Inc reported operating income of -$7.1 million for fiscal 2012 (the year ended Dec 31, 2012), against $2.4 million the year before (-392.4%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What was Astex Pharmaceuticals, Inc's cash from operating activities in fiscal 2012?
- Astex Pharmaceuticals, Inc reported cash from operating activities of $18 million for fiscal 2012 (the year ended Dec 31, 2012), against $12.4 million the year before (+45.9%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What was Astex Pharmaceuticals, Inc's free cash flow in fiscal 2012?
- Astex Pharmaceuticals, Inc reported free cash flow of $17 million for fiscal 2012 (the year ended Dec 31, 2012), against $11 million the year before (+54.8%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What are Astex Pharmaceuticals, Inc's total assets?
- As of Dec 31, 2012, Astex Pharmaceuticals, Inc reported total assets of $275.2 million, against $276.9 million a year earlier (-0.6%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What are Astex Pharmaceuticals, Inc's total liabilities?
- As of Dec 31, 2012, Astex Pharmaceuticals, Inc reported total liabilities of $38.2 million, against $56.9 million a year earlier (-32.9%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
- What are Astex Pharmaceuticals, Inc's cash and cash equivalents?
- As of Dec 31, 2012, Astex Pharmaceuticals, Inc reported cash and cash equivalents of $15.5 million, against $39.8 million a year earlier (-61.1%). Source: the 10-K filed with the SEC on Mar 18, 2013. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:919722&period_type=annual&limit=5"Information only, not investment advice.